Combination of Surgery and Standard Therapy Increases Survival in Stage IV, Study Says June 30, 2016Vol.39 No.06
FreeTCCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months October 01, 2014Vol.37 No.09
FreeTCCL Archive ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer May 29, 2014Vol.37 No.05
FreeTCCL Archive Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen May 01, 2014Vol.37 No.04
FreeTCCL Archive Study Shows MammaPrint Test Can Predict 25-Year Breast Cancer Risk Levels February 27, 2014Vol.37 No.02
FreeTCCL Archive Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk February 03, 2014Vol.37 No.01
